Ligand validation:4GBY

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 4GBY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GBY_BNG_A_505	28%	66%	0.27	0.925	0.42	0.88	-	1	0	0	100%	1
4GBY_BNG_A_502	21%	65%	0.325	0.936	0.42	0.91	-	1	5	0	100%	1
4GBY_BNG_A_504	12%	68%	0.345	0.873	0.46	0.77	-	-	2	0	100%	1
4GBY_BNG_A_503	6%	61%	0.328	0.772	0.46	1.02	-	2	1	0	100%	1
4GC0_BNG_A_505	16%	44%	0.233	0.806	0.57	1.58	-	7	2	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4DVE_BNG_B_202	81%	66%	0.092	0.945	0.47	0.83	-	1	0	0	100%	0.5
5B0W_BNG_F_304	74%	49%	0.088	0.917	1.25	0.73	3	-	2	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
4MUU_BNG_A_202	70%	41%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.